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carboxymethyl cellulose (CMC) has been effectively synthesized with high yield and purity. With the prolongation of 
time after model establishment, the values of Schirmer Ⅰ test (S Ⅰ t) and breakup time of tear film gradually decreased. The 
α-MSH and CMC alone could ameliorate corneal tissue damage and corneal morphological abnormalities in the dry eye to 
some extent. However, compared with monotherapy, the treatment of α-MSH combined with CMC has a more significant 
positive effect on the improvement of tear secretion and the stability of tear film in dry eye model in the early stage after 
modeling. There are significant differences between the model control group and the normal control group at each time 
point after model establishment (all P<0.01) at 7th, 14th, 21th and 28th days after treatment. After 7, 14 and 21 days treatment, 
the S Ⅰ t values in the α-MSH+CMC treatment group were 4.80±0.79, 4.10±0.52 and 4.30±0.86 mm, respectively. 
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Dry eye is a disease of the abnormal tear film and 
ocular surface caused by multiple factors, which is 
mainly manifested as the increase of tear film osmotic 
pressure and ocular discomfort, vision fluctuation, 
tear film instability, and other symptoms caused by 
ocular surface inflammation
1
. Studies have shown that 
the prevalence of dry eye is 5% to 34%, and the 
incidence is higher in women and the elderly 
population
2
, especially. Improper treatment may lead 
to ocular surface inflammation, corneal damage, 
decreased vision, and even blindness. There are 
several different therapeutic methods in the treatment 
of dry eye, which includes the topical application of 
artificial tears, immunosuppressive agents, and non-
steroidal drugs. The main functions of those methods 
depend on the promotion of the secretion of tears and 
inhibition of the inflammatory response, which can 




Sodium carboxymethylcellulose (CMC), a 
multifunctional polymer compound obtained by 
chemically modifying natural cellulose, has been 
widely used in the fields of food, medicine, and 
textiles. Notably, CMC, as an artificial tear, is 
clinically mainly applied for the treatment of the dry 
eye. CMC has a large content of anionic and 
hydrophilic groups, which has a good adhesiveness 
and has the capability of diluting inflammatory 
factors, stabilizing the tear film, and wetting the 
ocular surface. At the same time, artificial tears 
contain a variety of electrolytes, which can maintain 
the metabolic balance of ocular surface tissues and 
relieve several symptoms of dry eye. α-Melanocyte-
stimulating hormone (α-MSH) is derived from an 
opioid-melanocyte-stimulating prohormone. Previous 
studies have confirmed that α-MSH can reduce dry 
eye symptoms and inhibit the production of 
inflammatory factors
6
. However, it is not clear yet 
whether α-MSH can positively promote the 
therapeutic effect of CMC on dry eye. In the current 
study, the co-treatment of α-MSH and CMC was 
proposed to treat dry eye induced by scopolamine 
hydrobromide. Meanwhile, the clinical indicators and 
the improvement of and morphological changes of 
keratoconjunctiva and keratoconjunctiva after the  
co-treatment of α-MSH and CMC were assessed. 
 
Materials and Methods 
 
Materials 
Scopolamine hydrobromide (Sigma, USA); α-MSH 
(Calbiochem, USA); tear secretion phenol red cotton 
thread (Tianjin Jingming New Technology 
Development Co., Ltd, China.); fluorescein sodium 




injection (Alcon, USA); periodic acid Schiff (PAS) 
kit (Roche, USA). Slit-lamp microscope (Chongqing 
Kanghua Technology Co., Ltd.); BX51 optical 




Six weeks old Wistar rats, half male and half 
female, weighing 160 to 180 g, were obtained by 
Experimental animal center of PLA Academy of 
military medical sciences. All the animals were 
housed in the clean animal laboratory of Tianjin 
Medical University, with free access to water and 
food, the indoor temperature of (25±1)℃, the relative 
humidity of (40±5)%, and 12 h light/12 h dark 
periodic light. 
 
Results and Discussion 
 
Synthesis of CMC (IR spectrum of CMC)  
Crushing cellulose as a raw materials to 20 microns 
with a plant fiber pulverizer to obtain cellulose 
powder; 20 g of tetrabutylammonium fluoroborate 
and 2 kg of the pulverized cellulose powder were 
successively poured into 25 L of isopropanol solution 
and stirred to obtain the premix; then the subsequent 
reaction was carried out under nitrogen atmosphere. 
The premix is heated to 25℃, and then 9.1 L of 
sodium hydroxide solution (mass concentration of 
10%) is added dropwise, and the basification reaction 
mixture is obtained after 0.5 h of reaction. The 
alkalization reaction solution is heated to 50℃ and 
reacted with 2.4 kg sodium monochloroacetate for 2 h 
to obtain the etherification reaction solution. The 
etherified reaction solution is naturally cooled to room 
temperature, and then added to the methanol solution 
for soaking for 8 h. 70% acetic acid was used for 
neutralize the aged reaction solution, adjusting pH to 
6~8, then filter it to obtain filter residue. Washing the 
filter residue with ethanol with a volume 
concentration of 70% for 5 times and sodium 
carboxymethyl cellulose was obtained by drying the 
washed filter residue in a drying oven at 60°C in 
isolated air, with a molecular weight of 778,000 and a 
viscosity of 52,415 mPa s, with a substitution degree 
of 0.91, and chlorine content of 0.18 wt%. CMC were 
well prepared with high yield and purity, and its 
corresponding FTIR spectra and structure diagram 
were shown in Figs 1 & 2, respectively.  
 
Dry eye modeling, Grouping, treatment and examinations 
The dry eye model was established based on the 
method described in the literature
6,7
, 0.5 mL 
scopolamine hydrobromide (6 mL, dissolved in 0.9% 
NaCl solution) was subcutaneously injected 
alternately into the hind limbs at 9: 00, 12: 00, 15: 00, 
and 18: 00 every day for 28 days 
60 animals were randomly divided into normal 
control group, model control group, NaCI treatment 
group, CMC treatment group, and α-MSH treatment 
group and α-MSH + CMC treatment group, 10 
animals in each group. Apart from the normal control 
group, the dry eye model was established in all the 









Fig. 2 ⸺ Structure diagram of sodium carboxymethylcellulose 
 




injection of scopolamine hydrobromide on, normal 
saline, 0.5% CMC eye drops, normal saline 
containing 1 × 10
-3
mg/mL α-MSH and 0.5% CMC 
eye drops containing 10 mg/mL α-MSH dropped into 
right eyes, respectively, according to the above groups 
with twice a day (8: 00 h, 17: 00 h), each time 25 μl, 
for 28 days, while the normal control group received 
no treatment. Each group underwent Schirmer Ⅰ test, 
(S Ⅰ t), breakup time of tear film (BUT), and corneal 









 days after the establishment of dry eye 
model. After the above examinations were completed on 
the 28
th
 day after model establishment, 10% chloral 
hydrate (0.3 mL/100 g body weight) was injected 
intraperitoneally for general anesthesia. The eyeballs 
with upper eyelids, lower eyelids, and intact conjunctiva 
were taken and placed in 4% paraformaldehyde for 
fixation. Each group was examined at the same time 








 days after 
the establishment of the model. 
The S Ⅰ t value and BUT value of the right eye of 
the normal control group decreased slightly with time, 
and the S Ⅰ t value of the model control group was 
slightly lower than that of the normal control group 
before modeling, but the difference was not 









days after model establishment, the S Ⅰ t 
value decreased gradually, and the S Ⅰ t level at each 
time point was significantly lower than that of a 
normal control group, and the differences were 
statistically significant (all P < 0.001). The BUT 
values in the model control group were similar to 
those of the normal control group before modeling, 









after modeling, and the BUT at each time point was 
significantly lower than that of the normal control 
group, and the differences were statistically 
significant (all P < 0.001). 
 
Changes in dry eye-related parameters 
There were significant differences in tear secretion 
between the groups at different time points after 
intervention (Fgroup = 234.300, P = 0.000; Ftime = 
65.620, P = 0.000). The tear secretion o in the model 
control group gradually decreased with the 
prolongation of modeling time. Compared with the 7
th 
day after treatment, except for the normal control 
group, the tear secretion in each group decreased, and 
the differences had statistical significance (all P < 
0.001). There was no significant difference in the 
other time points before and after treatment in each 









after treatment, the levels of S Ⅰ t were significantly 
lower than those in normal controls (all P< 
0.01).There was no significant difference in S Ⅰ t 
values between the model control group and NaCl 
group at each time point after treatment (all P> 
0.05).There was no significant difference in S Ⅰ t 
value between the CMC group and the α-MSH + 







 days after treatment, the S Ⅰ t value of α-MSH 
+ CMC group was significantly higher than that of 
NaCl group (all P < 0.01), but there was no significant 
difference among NaCl group, CMC group and α-
MSH group (all P> 0.05).28 days after treatment, 
there was no significant difference in S Ⅰ t values 
between NaClgroup and CMC group, α-MSH group, 
and α-MSH + CMC group (all P> 0.05) as shown in 
Table 1. 
 
Comparison of BUT values at different time points after 
treatment of each group 
There were significant differences in the overall 
comparison of BUT values at different time points 
after intervention among the groups of rats (Fgroup = 
540.000, P = 0.000; Ftime = 30.030, P = 0.000). 
Compared with 7
th
 d after treatment, apart from the 
normal control group, the BUT values of rats 
presented a reduction in each group, and the 
differences had statistical significance (all P< 0.01). 
 
Table 1 ⸺ Comparison of S Ⅰ t values at different time points after the administration of each group( sx  , mm) 
Groups Sample size S Ⅰ t values at different time points 
0d 7d 14d 21d 28d 
Normal control 10 7.250±1.244 7.156±1.247 5.031±1.958 5.047±1.073 5.100±0.835 
Model control 10 6.111±1.711 4.050±0.826ac 2.15O±O.490a 2.100±0.681a 1.975±0.638a 
NaCl 10 7.688±1.352 2.875±O.719ac 2.375±O.619a 2.532±0.957a 3.321±1.067a 
CMC 10 7.300±1.160 4.200±0.422ac 3.450±0.780a 3.500±0.882a 2.800±0.587a 
α-MSH 10 6.750±0.931 3.561±0.814ac 3.562±0.479a 3.50O±1.049a 4.214±0.935a 
α-MSH+CMC 10 7.700±1.252 4.800±0.789abc 4.100±0.516ab 4.300±0.856a 3.450±0.832a 
[Note: Fgroup = 234.300, P = 0.000; Ftime = 65.620, P = 0.000. Compared with the normal control group at their respective time points, 
aP< 0.01; compared with the NaCl group of their respective time points, bP< 0.01; compared with the 0 d value within the group,cP< 
0.01 (two-way analysis of variance, Tukey test); S Ⅰ t : Schirmer Ⅰ test; CMC : sodium carboxymethyl cellulose; α-MSH : melanocyte 
stimulating hormone] 
 






 day after treatment, the BUT of the model 
control group, α-MSH treatment group, and α-MSH + 
CMC treatment group decreased compared with 7
th
 day 
after treatment, and the differences had statistical 
significance (all P< 0.01). There was no significant 
difference between the groups before and after other 
time points (all P> 0.05).With the prolongation of time, 
the BUT values of the model control group gradually 
shortened, and the BUT values of the rats at each time 
point after modeling were significantly lower than 
those of the normal control group, and the differences 
were statistically significant (all P <0.01).There was no 
significant difference in BUT values between the 
model control group and the NaCl group at each time 








 days after 
treatment, the BUT values of rats were significantly 
lower than that of the normal control group, and the 
differences were statistically significant (all P< 0.01). 
There was no significant difference in the BUT values 
between the CMC treatment group and NaCl treatment 
group (all P> 0.05).On the 7
th 
day after treatment, the 
BUT of rats in the α-MSH treatment group as well as 
α-MSH + CMC treatment group was higher than that 
in the NaCl treatment group, and the differences were 
statistically significant (all P< 0.01).There was no 
significant difference in BUT values among the CMC 
treatment group as well as α-MSH treatment group 
and α-MSH + CMC treatment group at each time 
point (all P> 0.05) as shown in Table 2. 
 
Statistical Analysis 
Statistical analysis was performed using SPSS 20.0 
statistical software (IBM, USA). The data of each test 
indicator in the current study were normally 
distributed by Shapiro–Wilk test expressed as sx  . 
The variance of each group of data was equal by the 
Levene test. A completely randomized covariance 
study design was used. The differences of S Ⅰ t value, 
BUT value and corneal fluorescein staining score 
between the normal control group and the model 
control group were compared using the independent 
sample t-test. The overall differences of S Ⅰ t value, 
BUT value and corneal fluorescein staining score in 
the right eyes in the normal control group, model 
control group and various drug eye point groups at 
different time points after intervention were compared 
using two-way analysis of variance, and multiple 
comparisons were performed using Tukey test; P< 
0.05 was considered statistically significant. 
 
Results and Discussion 
It is generally known that tear film components are 
composed of a watery liquid layer, a mucin layer, and a 
lipid layer. Meanwhile, the quality and quantity of each 
layer component and their intrinsic interactionall play 
an important role in maintaining the balance of the tear 
film
7
.The pathogenesis of dry eye is extremely 
complex, and various pathogenic factors act on ocular 
surface tissues to cause an increase in tear osmolality, 
apoptosis of keratocytes, and atrophy of conjunctival 
goblet cells, which may have a negative impact on the 
secretion of the glands and nerve conduction
8-11
.Dry 
eye is divided into tear evaporation overstrong type and 
underproduction type, thereby resulting in a large 
spectrum of induction methods of dry eye models, such 
as destroying animal meibomian glands, controlling 
environmental factors, applying epinephrine, atropine 
or glucocorticoids, removing lacrimal glands, 
destroying or interfering with nerve reflexes and so on, 
but the models elicited by these methods have several 
shortcomings including instability, excessive 
complications, etc. In the current study, scopolamine 
hydrobromide, a cholinergic M receptor blocker, was 
subcutaneously injected to simulate the dry eye model 
with reduced tear production, which has the 
characteristics of long-lasting effects and simple 
operation. Accordingly, this model elicited by 
scopolamine hydrobromide can be used to explore and 
study novel intervention measures and mechanisms of 
dry eye.In our research, we compared and investigated 
 
Table 2 ⸺ Comparison of BUT values at different time points after treatment of each group ( sx  , s) 
Groups Sample 
size 
BUT valuesat different time points 
0 d 7 d 14 d 21 d 28 d 
Normal control 10 8.406±1.188 6.125±1.454 4.813±1.203 3.844±0.884 3.467±0.681 
Model control 10 8.750±1.020 3.800±1.056ac 2.000±0.324ad 1.700±0.470a 2.100±0.447a 
NaCl 10 8.813±1.424 3.250±1.000ac 2.250±O.447a 2.125±0.342a 2.214±0.456a 
CMC 10 8.300±1.767 4.000±0.816ac 2.400±0.699a 2.500±0.527a 2.300±0.483a 
α-MSH 10 8.625±1.088 4.938±1.843abc 3.063±0.443ad 3.250±0.577a 3.143±0.663a 
α-MSH+CMC 10 8.100±1.970 5.000±1.491abc 3.100±0.738ad 3.100±0.316a 2.900±0.316a 
[Note: Fgroup = 540. 000, P = 0.000; Ftime = 30. 030, P = 0.000. Compared with the normal control group at their respective time 
points, aP< 0.01; compared with the NaCl group of their respective time points, bP< 0.01; compared with the 0 d value within the 
group,cP< 0.01, compared with 7 d value within group, dP< 0.01 (two-way analysis of variance, Tukey test); BUT: breakup time of 
tear film; CMC: sodium carboxymethylcellulose; α-MSH: melanocyte stimulating hormone] 
 
 




the therapeutic effect of α-MSH combined with CMC 
and other treatment in dry eye model elicited by 
scopolamine hydrobromide, and the combination of  
α-MSH and CMC in the early stage after modeling 
could significantly increase the tear secretion of dry eye 
model and alleviate the decrease of BUT in dry eye 
model than other groups. Intriguingly, CMC had no 
significant effect on tear film stability in the dry eye 
model, while the combination treatment of α-MSH and 
CMC presents a great alleviation of corneal injury in the 
dry eye model. 
 
These studies have shown that the co-treatment of  
α-MSH and CMC can significantly enhance the relief 
of ocular surface function caused by dry eye, including 
increasing tear secretion, stabilizing tear film, and 
reducing corneal damage. However, it was found that 
the combination of α-MSH and CMC did not obviously 
enhance the alleviating effect of tear secretion on the 
28
th
 day in the dry eye model. After discreet discussion, 
we analyzed and speculated the possible reason 
resulting in this phenomenon was the progressive 
aggravation of damage to the ocular surface by intra 
peritoneal injection of scopolamine hydrobromide at a 
later stage, which exceeded the protective effect of the 
drug. In conclusion, the results of this experiment 
effectively indicate that the combination treatment of 
α-MSH and CMC exerts a synergistic and positive 
effect on the treatment of the dry eye. 
 
At present, the treatment of dry eye is mainly based 
on artificial tears, and its key active ingredient is 
CMC
12
. CMC is an anionic cellulose water-soluble 
polymer with carboxyl groups, which has great 
adhesion. Besides, its anionic characteristics has a wide 
range of utilization, such as increasing the residence 
time on the ocular surface
13
, promoting the binding to 
ocular surface cells, exert an essential role in 
promoting epithelial cell regeneration16, lubricating 
the ocular surface and stabilizing the tear film and so 
on
14,15
. Undoubtedly, drugs such as artificial tears and 
lubricants indeed have a positive effect on relieve the 
symptoms of dry eye, and sodium hyaluronate eye 
drops have been confirmed to have some efficacy in 
the treatment of dry eye in clinical studies, but they fail 
to cure or control dry eye etiologically. Studies have 
suggested that inflammation is a significant pathogenic 
factor in the development and progression of dry eye
16
, 
while α-MSH has a powerful anti-inflammatory effect 
and can repair corneal epithelial injury effectively
17
.In 
previous studies, Ru et al.
6
 have proven that α-MSH 
could alleviate the reduction of tear secretion, increase 
tear film stability, inhibit apoptosis, reduce corneal 
edema, maintain corneal integrity, and inhibit the over 
expression of pro-inflammatory factors on the ocular 
surface by activating the PKA-CREB and MEK-ERK 
pathways. Moreover, it also can inhibit the expression 
of pro-inflammatory cytokines intercellular adhesion 
molecule-1 and tumor necrosis factor-α (TNF-α), and 
promote the expression of intercellular tight junction 
component occludin in the retina of streptozotocin-
induced diabetic animals, which thereby reduce retinal 
vascular leakage and protect retinal function. The 
aforementioned results of our current study also 
showed that the combination of α-MSH with CMC 
could further improve the ocular surface signs of dry 
eye, which thus exertsan effect of cell protection and 
inhibition of corneal edema. Luger et al.
18
 found that α-
MSH inhibited proinflammatory factors in corneal 
injury, expression of corneal and uveal in an animal 
model of immune uveitis and the activation of 
inflammatory response pathways such as nuclear 
factor-KB. On the other hand, it also could regulate the 
proliferation, viability, and migration of inflammatory 
cells to some extent. In addition, clinical studies and 
animal experiments have confirmed that the expression 
of ocular surface inflammasomes and proinflammatory 
factors such as interleukin-1α and TNF-the α is up-
regulated in the dry eye state
19-21
, which may suggest 
that α-MSH has a great potential to enhance the 
therapeutic effect of CMC on dry eye by mean of 




In summary, the results of our study presented that 
the treatment of α-MSH combined with CMC could 
effectively alleviate the ocular signs of dry eye elicited 
by subcutaneous injection of scopolamine hydrobromide 
and exerted a more significant effect than α-MSH or 
CMC alone. Our study provides a new idea for further 
exploration and development of the intervention 
approaches of dry eye drugs, however, its specific 
mechanism of action remains to be further explored. 
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